Anlotinib In Combination With PD-1/L1 Inhibitor As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study
Latest Information Update: 07 Mar 2022
At a glance
- Drugs Catequentinib (Primary) ; Durvalumab (Primary) ; Toripalimab (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 23 Mar 2020 New trial record